# Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease

> **NCT06422208** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Penelope J. Hallett, Ph.D.** · enrollment: 6 (estimated)

## Conditions studied

- Parkinson Disease

## Interventions

- **BIOLOGICAL:** Autologous midbrain dopamine neurons

## Key facts

- **NCT ID:** NCT06422208
- **Lead sponsor:** Penelope J. Hallett, Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-08-07
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422208, "Autologous iPSC-Derived Dopamine Neuron Transplantation for Parkinson's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06422208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*